EXC vs JNJ · P/E 17, rev $24.26B vs P/E 17, rev $49.37B
Exelon Corporation (EXC) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the EXC and JNJ stock pages for the full models.
Not investment advice.